Modulation of signal transduction by vitamin E

Molecular Aspects of Medicine

Volumn 28, Issue 5-6, 2007, Pages 481-506

  Zingg, Jean Marc ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Gene expression; Membrane translocation; Protein kinase; Protein phosphatase; Signal transduction; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; CELL SURFACE RECEPTOR; CYCLOOXYGENASE 2; CYTOKINE; DIACYLGLYCEROL KINASE; GROWTH FACTOR; LIPID; PHOSPHOLIPASE A2; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

CELL INTERACTION; CELL STIMULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENZYME ACTIVATION; ENZYMES; HUMANS; SIGNAL TRANSDUCTION; VITAMIN E;

EID: 35448939592     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2006.12.009     Document Type: Review

References (169)

1. Abate A., Yang G., Dennery P.A., Oberle S., and Schroder H. Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin. Free Radic. Biol. Med. 29 11 (2000) 1135-1142
2. Ahn K.S., Sethi G., Krishnan K., and Aggarwal B.B. gamma-tocotrienol inhibits nuclearfactor-kappaB signaling pathway through inhibition of RIP and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol. Chem. 282 1 (2006) 809-820
3. Akazawa A., Nishikawa K., Suzuki K., Asano R., Kumadaki I., Satoh H., Hagiwara K., Shin S.J., and Yano T. Induction of apoptosis in a human breast cancer cell overexpressing ErbB-2 receptor by alpha-tocopheryloxybutyric acid. Jpn. J. Pharmacol. 89 4 (2002) 417-421
4. Akeson A.L., Woods C.W., Mosher L.B., Thomas C.E., and Jackson R.L. Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 86 2-3 (1991) 261-270
5. Andjelkovic M., Jakubowicz T., Cron P., Ming X.F., Han J.W., and Hemmings B.A. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 93 12 (1996) 5699-5704
6. Andresen B.T., Rizzo M.A., Shome K., and Romero G. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade. FEBS Lett. 531 l (2002) 65-68
7. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., and Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J. Immunol. 172 4 (2004) 2522-2529
8. Azzi A., Gysin R., Kempna P., Ricciarelli R., Villacorta L., Visarius T., and Zingg J.M. Regulation of gene and protein expression by vitamin E. Free Radic. Res. 36 1 (2002) 30-35
9. Barrett W.C., DeGnore J.P., Keng Y.F., Zhang Z.Y., Yim M.B., and Chock P.B. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase IB. J. Biol. Chem. 274 49 (1999) 34543-34546
10. Barthel A., and Klotz L.O. Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress. Biol. Chem. 386 3 (2005) 207-216
11. Black T.M., Wang P., Maeda N., and Coleman R.A. Palm tocotrienols protect ApoE +/- mice from diet-induced atheroma formation. J. Nutr. 130 10 (2000) 2420-2426
12. Boscoboinik D., Szewczyk A., Hensey C., and Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266 10 (1991) 6188-6194
13. Boudreau R.T., Garduno R., and Lin T.J. Protein phosphatase 2A and protein kinase Calpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J. Biol. Chem. 277 7 (2002) 5322-5329
14. Bradford A., Atkinson J., Fuller N., and Rand R.P. The effect of vitamin E on the structure of membrane lipid assemblies. J. Lipid. Res. 44 10 (2003) 1940-1945
15. Breyer I., and Azzi A. Differential inhibition by alpha- and beta-tocopherol of human erythroleukemia cell adhesion: role of integrins. Free Radic. Biol. Med. 30 12 (2001) 1381-1389
16. Brigelius-Flohe R., Kelly F.J., Salonen J.T., Neuzil J., Zingg J.M., and Azzi A. The European perspective on vitamin E: current knowledge and future research. Am. J. Clin. Nutr. 76 4 (2002) 703-716
17. Brigelius-Flohe R., Kluth D., and Banning A. Is there a future for antioxidants in atherogenesis?. Mol. Nutr. Food Res. 49 11 (2005) 1083-1089
18. Brigelius-Flohe R., and Traber M.G. Vitamin E: function and metabolism. FASEB. J. 13 10 (1999) 1145-1155
19. Cachia O., Benna J.E., Pedruzzi E., Descomps B., Gougerot-Pocidalo M.A., and Leger C.L. alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J. Biol. Chem. 273 49 (1998) 32801-32805
20. Cai Z., and Semenza G.L. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ. Res. 97 12 (2005) 1351-1359
21. Chan S.S., Monteiro H.P., Schindler F., Stern A., and Junqueira V.B. Alpha-tocopherol modulates tyrosine phosphorylation in human neutrophils by inhibition of protein kinase C activity and activation of tyrosine phosphatases. Free Radic. Res. 35 6 (2001) 843-856
22. Chandra V., Jasti J., Kaur P., Betzel C., Srinivasan A., and Singh T.P. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution. J. Mol. Biol. 320 2 (2002) 215-222
23. Cho W., and Stahelin R.V. Membrane-protein interactions in cell signaling and membrane trafficking. Annu. Rev. Biophys. Biomol. Struct. 34 (2005) 119-151
24. Cipres A., Carrasco S., Merino E., Diaz E., Krishna U.M., Falck J.R., Martinez A.C., and Merida I. Regulation of diacylglycerol kinase alpha by phosphoinositide 3-kinase lipid products. J. Biol. Chem. 278 37 (2003) 35629-35635
25. Clement S.A., Tan C.C., Guo J., Kitta K., and Suzuki Y.J. Roles of protein kinase C and alpha-tocopherol in regulation of signal transduction for GATA-4 phosphorylation in HL-1 cardiac muscle cells. Free Radic. Biol. Med. 32 4 (2002) 341-349
26. Cojocel C., Al-Maghrebi M., Thomson M.S., Rawoot P., and Raghupathy R. Modulation of the transforming growth factor betal by vitamin E in early nephropathy. Med. Princ. Pract. 14 6 (2005) 422-429
27. Cui T., Schopfer F.J., Zhang J., Chen K., Ichikawa T., Baker P.R., Batthyany C., Chacko B.K., Feng X., Patel R.P., et al. Nitrated fatty acids: endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 281 47 (2006) 35686-35698
28. Cunnick J.M., Dorsey J.F., Mei L., and Wu J. Reversible regulation of SHP-1 tyrosine phosphatase activity by oxidation. Biochem. Mol. Biol. Int. 45 5 (1998) 887-894
29. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., and Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKTby the integrin-linked kinase. Proc. Natl. Acad. Sci. U.S.A. 95 19 (1998) 1211-1216
30. Denu J.M., and Tanner K.G. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37 16 (1998) 5633-5642
31. Devaraj S., Adams-Huet B., Fuller C.J., and Jialal I. Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation. Arterioscler. Thromb. Vase. Biol. 17 10 (1997) 2273-2279
32. Devaraj S., and Jialal I. Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler. Thromb. Vase. Biol. 19 4 (1999) 1125-1133
33. Devaraj S., Li D., and Jialal I. The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J. Clin. Invest. 98 3 (1996) 756-763
34. Donapaty S., Louis S., Horvath E., Kun J., Sebti S.M., and Malafa M.P. RRR-alpha-tocopherol succinate down-regulates oncogenic Ras signaling. Mol. Cancer Ther. 5 2 (2006) 309-316
35. Douglas C.E., Chan A.C., and Choy P.C. Vitamin E inhibits platelet phospholipase A2. Biochim. Biophys. Acta 876 3 (1986) 639-645
36. Egger T., Hammer A., Wintersperger A., Goti D., Malle E., and Saltier W. Modulation of microglial superoxide production by alpha-tocopherol in vitro: attenuation of p67phox translocation by a protein phosphatase-dependent pathway. J. Neurochem. 79 6 (2001) 1169-1182
37. Egger T., Schuligoi R., Wintersperger A., Amann R., Malle E., and Sattler W. Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia. Biochem. J. 370 Pt 2 (2003) 459-467
38. Farooqui A.A., Ong W.Y., and Horrocks L.A. Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol. Rev. 58 3 (2006) 591-620
39. Feng J., Park J., Cron P., Hess D., and Hemmings B.A. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem. 279 39 (2004) 41189-41196
40. Ferri P., Cecchini T., Ambrogini P., Betti M., Cuppini R., Grande P.D., and Ciaroni S. alpha-tocopherol affects neuronal plasticity in adult rat dentate gyrus: The possible role of PKCdelta. J. Neurobiol. 66 8 (2006) 793-810
41. Fetrow J.S., Slew N., and Skolnick J. Structure-based functional motif identifies a potential disulfide oxidoreductase active site in the serine/threonine protein phosphatase-1 subfamily. Faseb. J. 13 13 (1999) 1866-1874
42. Finkel T. Redox-dependent signal transduction. FEES Lett. 476 1-2 (2000) 52-54
43. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 15 2 (2003) 247-254
44. Frank G.D., Eguchi S., Yamakawa T., Tanaka S., Inagami T., and Motley E.D. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II. Endocrinology 141 9 (2000) 3120-3126
45. Freedman J.E., Farhat J.H., Loscalzo J., and Keaney Jr. J.F. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94 10 (1996) 2434-2440
46. Fukunaga-Takenaka R., Shirai Y., Yagi K., Adachi N., Sakai N., Merino E., Merida I., and Saito N. Importance of chroman ring and tyrosine phosphorylation in the subtype-specific translocation and activation of diacylglycerol kinase alpha by d-alpha-tocopherol. Genes Cells 10 4 (2005) 311-319
47. Galli F., Stabile A.M., Betti M., Conte C., Pistilli A., Rende M., Floridi A., and Azzi A. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation. Arch. Biochem. Biophys. 423 1 (2004) 97-102
48. Gills J.J., and Dennis P.A. The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, Akt. Expert Opin. Investig. Drugs 13 7 (2004) 787-797
49. Grammas P., Hamdheydari L., Benaksas E.J., Mou S., Pye Q.N., Wechter W.J., Floyd R.A., Stewart C., and Hensley K. Anti-inflammatory effects of tocopherol metabolites. Biochem. Biophys. Res. Commun. 319 3 (2004) 1047-1052
50. Grau A., and Ortiz A. Dissimilar protection of tocopherol isomers against membrane hydrolysis by phospholipase A2. Chem. Phys. Lipids 91 2 (1998) 109-118
51. Grossman S., and Waksman E.G. New aspects of the inhibition of soybean lipoxygenase by alpha-tocopherol. Evidence for the existence of a specific complex. Int. J. Biochem. 16 3 (1984) 281-289
52. Guinea Viniegra J., Martinez N., Modirassari P., Hernandez Losa J., Parada Cobo C., Sanchez-Arevalo Lobo V.J., Avceves-Luquero C.I., Alavrez-Vallina L., Ramon Y.C.S., Rojas J.M., et al. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J. Biol. Chem. 280 6 (2004) 429-436
53. Hehenberger K., and Hansson A. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem. Funct. 15 3 (1997) 197-201
54. Hensley K., Benaksas E.J., Bolli R., Comp P., Grammas P., Hamdheydan L., Mou S., Pye Q.N., Stoddard M.F., Wallis G., et al. New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic. Biol. Med. 36 1 (2004) 1-15
55. Hicke L. Gettin' down with ubiquitin: turning off cell-surface receptors, transporters and channels. Trends Cell Biol. 9 3 (1999) 107-112
56. Hicke L. Protein regulation by monoubiquitin. Nat. Rev. Mol. Cell Biol. 2 3 (2001) 195-201
57. Hill M.M., and Hemmings B.A. Inhibition of protein kinase B/Akt implications for cancer therapy. Pharmacol. Ther. 93 2-3 (2002) 243-251
58. Himmelfarb J., Kane J., McMonagle E., Zaltas E., Bobzin S., Boddupalli S., Phinney S., and Miller G. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 64 3 (2003) 978-991
59. Hurley J.H., and Misra S. Signaling and subcellular targeting by membrane-binding domains. Annu. Rev. Biophys. Biomol. Struct. 29 (2000) 49-79
60. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87 3 (2000) 179-183
61. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353 Pt 3 (2001) 417-439
62. Jiang Q., and Ames B.N. gamma-Tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB. J. 17 8 (2003) 816-822
63. Jiang Q., Christen S., Shigenaga M.K., and Ames B.N. gamma-Tocopherol, the major jorm of vitamin E in the US diet, deserves more attention. Am. J. Clin. Nutr. 74 6 (2001) 714-722
64. Jiang Q., Elson-Schwab I., Courtemanche C., and Ames B.N. gamma-Tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 97 21 (2000) 11494-11499
65. Kanno T., Utsumi T., Kobuchi H., Takehara Y., Akiyama J., Yoshioka T., Horton A.A., and Utsumi K. Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol. Free Radic. Res. 22 5 (1995) 431-440
66. Kawakami Y., Nishimoto H., Kitaura J., Maeda-Yamamoto M., Kato R.M., Littman D.R., Rawlings D.J., and Kawakami T. Protein kinase C betall regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J. Biol. Chem. 279 46 (2004) 47720-47725
67. Kempna P., Reiter E., Arock M., Azzi A., and Zingg J.M. Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway. J. Biol. Chem. 279 49 (2004) 50700-50709
68. Kempna P., Zingg J.M., Ricciarelli R., Hierl M., Saxena S., and Azzi A. Cloning of novel human SEC14p-like proteins: cellular localization, ligand binding and functional properties. Free Radic. Biol. Med. 34 (2003) 1458-1472
69. Khanna S., Roy S., Ryu H., Bahadduri P., Swaan P.W., Ratan R.R., and Sen C.K. Molecular basis of vitamin E action. Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-inducedneurodegeneration. J. Biol. Chem. 278 44 (2003) 43508-43515
70. Khor H.T., and Ng T.T. Effects of administration of alpha-tocopherol and tocotrienols on serum lipids and liver HMG CoA reductase activity. Int. J. Food Sci. Nutr. 51 Suppl. (2000) S3-S11
71. Klein A., Deckert V., Schneider M., Dutrillaux F., Hammann A., Athias A., Le Guern N., Pais de Barros J.P., Desrumaux C., Masson D., et al. Alpha-tocopherol modulates phosphatidylserine externalization in erythrocytes: relevance in phospholipid transfer protein-deficient mice. Arterioscler Thromb Vase Biol. 26 9 (2006) 2160-2167
72. Koya D., Lee I.K., Ishii H., Kanoh H., and King G.L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 8 3 (1997) 426-435
73. Kyaw M., Yoshizumi M., Tsuchiya K., Izawa Y., Kanematsu Y., and Tamaki T. Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. Acta Pharmacol. Sin. 25 8 (2004) 977-985
74. Kyaw M., Yoshizumi M., Tsuchiya K., Kirima K., and Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens. Res. 24 3 (2001) 251-261
75. Lee S.R., Kwon K.S., Kim S.R., and Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase IB in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273 25 (1998) 15366-15372
76. 2. J. Biol. Chem. 277 23 (2002) 20336-20342
77. Lepley R.A., Muskardin D.T., and Fitzpatrick F.A. Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J. Biol. Chem. 271 11 (1996) 6179-6184
78. Leslie N.R. The redox regulation of PI 3-kinase-dependent signaling. Antioxid. Redox Signal 8 9-10 (2006) 1765-1774
79. Leslie N.R., Bennett D., Lindsay Y.E., Stewart H., Gray A., and Downes C.P. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. Embo. J. 22 20 (2003) 5501-5510
80. Li-Weber M., Giaisi M., Treiber M.K., and Krammer P.H. Vitamin E inhibits IL-4 gene expression in peripheral blood T cells. Eur. J. Immunol. 32 9 (2002) 2401-2408
81. Li-Weber M., Weigand M.A., Giaisi M., Suss D., Treiber M.K., Baumann S., Ritsou E., Breitkreutz R., and Krammer P.H. Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J. Clin. Invest. 110 5 (2002) 681-690
82. Li D., Saldeen T., Romeo F., and Mehta J.L. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation 102 16 (2000) 1970-1976
83. Lin Y., Huang R., Santanam N., Liu Y.G., Parthasarathy S., and Huang R.P. Profiling of human cytokines in healthy individuals with vitamin E supplementation by antibody array. Cancer Lett. 187 1-2 (2002) 17-24
84. Linton M.F., and Fazio S. Cyclooxygenase-2 and inflammation in atherosclerosis. Curr. Opin. Pharmacol. 4 2 (2004) 116-123
85. Ludowyke R.I., Hoist J., Mudge L.M., and Sim A.T. Transient translocation and activation of protein phosphatase 2A during mast cell secretion. J. Biol. Chem. 275 9 (2000) 6144-6152
86. Ludowyke R.I., Warton K., and Scurr L.L. Inhibition of antigen and calcium ionophore induced secretion from RBL-2H3 cells by phosphatase inhibitors. Cell Biol. Int. 22 11-12 (1998) 855-865
87. Mahoney C.W., and Azzi A. Vitamin E inhibits protein kinase C activity. Biochem. Biophys. Res. Commun. 154 2 (1988) 694-697
88. Marmor M.D., and Yarden Y. Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene 23 11 (2004) 2057-2070
89. Martin-Nizard F., Boullier A., Fruchart J.C., and Duriez P. Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells. Cardiovasc. Risk 5 5-6 (1998) 339-345
90. Maziere C., Auclair M., Djavaheri-Mergny M., Packer L., and Maziere J.C. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells. Biochem. Mol. Biol. Int. 39 6 (1996) 1201-1207
91. Maziere C., Conte M.A., and Maziere J.C. Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic. Biol. Med. 31 11 (2001) 1334-1340
92. McLaughlin S., and Murray D. Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438 7068 (2005) 605-611
93. Meng T.C., Buckley D.A., Galic S., Tiganis T., and Tonks N.K. Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J. Biol. Chem. 279 36 (2004) 37716-37725
94. Meng T.C., Fukada T., and Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9 2 (2002) 387-399
95. Misra S., Miller G.J., and Hurley J.H. Recognizing phosphatidylinositol 3-phosphate. Cell 107 5 (2001) 559-562
96. Mo H., and Elson C.E. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J. Nutr. 129 4 (1999) 804-813
97. Mo H., and Elson C.E. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp. Biol. Med. (Maywood) 229 7 (2004) 567-585
98. Munteanu A., Ricciarelli R., and Zingg J.M. HIV protease inhibitors-induced atherosclerosis: prevention by alpha-tocopherol. IUBMB Life 56 10 (2004) 629-631
99. Munteanu A., Taddei M., Tamburini I., Bergamini E., Azzi A., and Zingg J.M. Antagonistic effects of oxidized low density lipoprotein and {alpha}-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-{gamma}. J. Biol. Chem. 281 10 (2006) 6489-6497
100. Munteanu A., Zingg J.M., and Azzi A. Anti-atherosclerotic effects of vitamin E - myth or reality?. J. Cell Mol. Med. 8 l (2004) 59-76
101. Munteanu A., Zingg J.M., Ricciarelli R., and Azzi A. CD36 overexpression in ritonavir-treated THP-1 cells is reversed by alpha-tocopherol. Free Radic. Biol. Med. 38 8 (2005) 1047-1056
102. Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., and Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J. Biol. Chem. 278 50 (2003) 50226-50233
103. Murray Jr. E.D., Wechter W.J., Kantoci D., Wang W.H., Pham T., Quiggle D.D., Gibson K.M., Leipold D., and Anner B.M. Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alpha. J. Pharmacol. Exp. Ther. 282 2 (1997) 657-662
104. Myhre O., Sterri S.H., Bogen I.L., and Fonnum F. Erkl/2 phosphorylation and reactive oxygen species formation via nitric oxide and Akt-l/Raf-1 crosstalk in cultured rat cerebellar granule cells exposed to the organic solvent 1,2,4-trimethylcyclohexane. Toxicol. Sci. 80 2 (2004) 296-303
105. Namgaladze D., Hofer H.W., and Ullrich V. Redox control of calcineurin by targeting the binuclear Fe(2+)-Zn(2+) center at the enzyme active site. J. Biol. Chem. 277 8 (2002) 5962-5969
106. Neuzil J., Weber T., Schroder A., Lu M., Ostermann G., Gellert N., Mayne G.C., Olejnicka B., Negre-Salvayre A., Sticha M., et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB. J. 15 2 (2001) 403-415
107. Ni J., Wen X., Yao J., Chang H.C., Yin Y., Zhang M., Xie S., Chen M., Simons B., Chang P., et al. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res. 65 21 (2005) 9807-9816
108. Nitti M., d'Abramo C., Traverse N., Verzola D., Garibotto G., Poggi A., Odetti P., Cottalasso D., Marinari U.M., Pronzato M.A., et al. Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons. Free Radic. Biol. Med. 38 7 (2005) 846-856
109. Numakawa Y., Nuniakawa T., Matsumoto T., Yagasaki Y., Kumamaru E., Kunugi H., Taguchi T., and Niki E. Vitamin E protected cultured cortical neurons from oxidative stress- induced cell death through the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. J. Neurochem. 97 4 (2006) 1191-1202
110. Oudit G.Y., Sun H., Kerfant B.G., Crackower M.A., Penninger J.M., and Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell Cardiol. 37 2 (2004) 449-471
111. Ozer N.K., Boscoboinik D., and Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem. Mol. Biol. Int. 35 1 (1995) 117-124
112. Packer L., Weber S.U., and Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J. Nutr. 131 2 (2001) 369S-373S
113. Parker R.A., Pearce B.C., Clark R.W., Gordon D.A., and Wright J.J. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J. Biol. Chem. 268 15 (1993) 11230-11238
114. Partovian C., and Simons M. Regulation of protein kinase B/Akt activity and Ser473 phosphorylation by protein kinase Calpha in endothelial cells. Cell Signal 16 8 (2004) 951-957
115. Pearce B.C., Parker R.A., Deason M.E., Qureshi A.A., and Wright J.J. Hypocholesterolemic activity of synthetic and natural tocotrienols. J. Med. Chem. 35 20 (1992) 3595-3606
116. Pentland A.P., Morrison A.R., Jacobs S.C., Hruza L.L., Hebert J.S., and Packer L. Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition. J. Biol. Chem. 267 22 (1992) 15578-15584
117. Qin S., and Chock P.B. Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PISK and Akt. Biochemistry 42 10 (2003) 2995-3003
118. Reddanna P., Rao M.K., and Reddy C.C. Inhibition of 5-lipoxygenase by vitamin E. FEBS Lett. 193 1 (1985) 39-43
119. Ricciarelli R., and Azzi A. Regulation of recombinant PKC alpha activity by protein phosphatase 1 and protein phosphatase 2A. Arch. Biochem. Biophys. 355 2 (1998) 197-200
120. Ricciarelli R., Tasinato A., Clement S., Ozer N.K., Boscoboinik D., and Azzi A. alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem. J. 334 Pt l (1998) 243-249
121. Ricciarelli R., Zingg J.M., and Azzi A. Vitamin E: protective role of a Janus molecule. FASEB. J. 15 13 (2001) 2314-2325
122. Rimbach G., Minihane A.M., Majewicz J., Fischer A., Pallauf J., Virgli F., and Weinberg P.D. Regulation of cell signalling by vitamin E. Proc. Nutr. Soc 61 4 (2002) 415-425
123. Rizzo M.A., Shome K., Watkins S.C., and Romero G. The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J. Biol. Chem. 275 31 (2000) 23911-23918
124. Romano M., and Claria J. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. Faseb. J. 17 14 (2003) 1986-1995
125. Salmeen A., Andersen J.N., Myers M.P., Meng T.C., Hinks J.A., Tonks N.K., and Barford D. Redox regulation of protein tyrosine phosphatase IB involves a sulphenyl-amide intermediate. Nature 423 6941 (2003) 769-773
126. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 5712 (2005) 1098-1101
127. Scheid M.P., and Woodgett J.R. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546 1 (2003) 108-112
128. Schopfer F.J., Lin Y., Baker P.R., Cui T., Garcia-Barrio M., Zhang J., Chen K., Chen Y.E., and Freeman B.A. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl. Acad. Sci. U.S.A. 102 7 (2005) 2340-2345
129. Sen C.K., Khanna S., and Roy S. Tocotrienols: Vitamin E beyond tocopherols. Life Sci. 78 18 (2006) 2088-2098
130. Sen C.K., Khanna S., Roy S., and Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 275 17 (2000) 13049-13055
131. Shah S., and Sylvester P.W. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells. Exp. Biol. Med. (Maywood) 229 8 (2004) 745-755
132. Shah S.J., and Sylvester P.W. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp. Biol. Med. (Maywood) 230 4 (2005) 235-241
133. Shiau C.W., Huang J.W., Wang D.S., Weng J.R., Yang C.C., Lin C.H., Li C., and Chen C.S. alpha -Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of BCL-XL/BCL-2 function. J. Biol. Chem. 281 17 (2006) 11819-11825
134. Sim A.T., Ludowyke R.I., and Verrills N.M. Mast cell function: Regulation of degranulation by serine/threonine phosphatases. Pharmacol. Ther. 112 2 (2006) 425-439
135. Simonsen A., and Stenmark H. PX domains: attracted by phosphoinositides. Nat. Cell. Biol. 3 8 (2001) E179-E182
136. Singh U., Devaraj S., and Jialal I. Vitamin E, oxidative stress, and inflammation. Annu. Rev. Nutr. 25 (2005) 151-174
137. Sommer D., Coleman S., Swanson S.A., and Stemmer P.M. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch. Biochem. Biophys. 404 2 (2002) 271-278
138. Stolzing A., Widmer R., Jung T., Voss P., and Grune T. Tocopherol-mediated modulation of age-related changes in microglial cells: Turnover of extracellular oxidized protein material. Free Radic. Biol. Med. 40 12 (2006) 2126-2135
139. Strous G.J., and Govers R. The ubiquitin-proteasome system and endocytosis. J. Cell Sci. 112 Pt 10 (1999) 1417-1423
140. Sylvester P.W., Mclntyre B.S., Gapor A., and Brisk K.P. Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation. Cell. Prolif. 34 6 (2001) 347-357
141. Sylvester P.W., Nachnani A., Shah S., and Briski K.P. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac. J. Clin. Nutr. 11 Suppl 7 (2002) S452-S459
142. Sylvester P.W., and Shah S.J. Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells. Front Biosci. 10 (2005) 699-709
143. Sylvester P.W., Shah S.J., and Samant G.V. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells. J. Plant Physiol. 162 7 (2005) 803-810
144. Tada H., Ishii H., and Isogai S. Protective effect of d-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metabolism 46 7 (1997) 779-784
145. Tan P.H., Sagoo P., Chan C., Yates J.B., Campbell J., Beutelspacher S.C., Foxwell B.M., Lombard G., and George A.J. Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J. Immunol. 174 12 (2005) 7633-7644
146. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., and Azzi A. d-α-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12190-12194
147. Teruel M.N., and Meyer T. Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell 103 2 (2000) 181-184
148. Teruel T., Hernandez R., and Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50 11 (2001) 2563-2571
149. Topham M.K. Signaling roles of diacylglycerol kinases. J. Cell Biochem. 97 3 (2006) 474-484
150. Tran K., and Chan A.C. R,R,R-alpha-tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specificity of the tocopherol molecule. Biochim. Biophys. Acta 1043 2 (1990) 189-197
151. Tran K., Proulx P.R., and Chan A.C. Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity. Biochim. Biophys. Acta 1212 2 (1994) 193-202
152. Urbe S. Ubiquitin and endocyticprotein sorting. Essays Biochem. 41 (2005) 81-98
153. Varlamov O., Kalinina E., Che F.Y., and Fricker L.D. Protein phosphatase 2A binds to the cytoplasmic tail of carboxypeptidase D and regulates post-trans-Golgi network trafficking. J. Cell Sci. 114 Pt 2 (2001) 311-322
154. Venkatraman J., and Meksawan K. Effects of dietary omega3 and omega6 lipids and vitamin E on chemokine levels in autoimmune-prone MRL/MpJ-lpr/lpr mice. J. Nutr. Biochem. 13 8 (2002) 479
155. Venugopal S.K., Devaraj S., and Jialal I. RRR-alpha-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition oftyrosine kinase (Tyk2). Atherosclerosis 175 2 (2004) 213-220
156. Venugopal S.K., Devaraj S., Yang T., and Jialal I. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 51 10 (2002) 3049-3054
157. Wang F., Wang T., Lai J., Li M., and Zou C. Vitamin E inhibits hemolysis induced by hemin as a membrane stabilizer. Biochem. Pharmacol. 71 6 (2006) 799-805
158. Wang Q., Theriault A., Gapor A., and Adeli K. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway. Biochem. Biophys. Res. Commun. 246 3 (1998) 640-643
159. Wei Q., and Xia Y. Proteasome inhibition down-regulates endothelial nitric-oxide synthase phosphorylation and function. J. Biol. Chem. 281 31 (2006) 21652-21659
160. Whiteman E.L., Cho H., and Bimbaum M.J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13 10 (2002) 444-451
161. Wu D., Mura C., Beharka A.A., Han S.N., Paulson K.E., Hwang D., and Meydani S.N. Age- associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am. J. Physiol. 275 3 Pt l (1998) C661-C668
162. Wu D.Y., Hayek M.G., and Meydani S.N. Vitamin E and macrophage cyclooxygenase regulation in the aged. J. Nutr. 131 2 (2001) 382S-388S
163. Yang Z.Z., Tschopp O., Baudry A., Dummler B., Hynx D., and Hemmings B.A. Physiological functions of protein kinase B/Akt. Biochem. Soc. Trans. 32 Pt 2 (2004) 350-354
164. Yano T., Yajima S., Hagiwara K., Kumadaki I., Yano Y., Otani S., Uchida M., and Ichikawa T. Vitamin E inhibits cell proliferation and the activation of extracellular signal-regulated kinase during the promotion phase of lung tumorigenesis irrespective ofantioxidative effect. Carcinogenesis 21 11 (2000) 2129-2133
165. Zheng T., Li W., Zhang A., Altura B.T., and Altura B.M. Alpha-tocopherol prevents ethanol-induced elevation of [Ca2+J]i in cultured canine cerebral vascular smooth musclecells. Neurosci. Lett. 245 1 (1998) 17-20
166. Zingg, J.M., 2006. Modulation of signal transduction by vitamin E; Davos. MedimondInternational Proceedings, pp. 47-60.
167. Zingg J.M., and Azzi A. Non-antioxidant activities of vitamin E. Cur. Med. Chem. 11 9 (2004) 1113-1133
168. Zingg J.M., and Azzi A. Modulation of Cellular Signalling and Gene Expression by Vitamin E. In: Bendrick O.H. (Ed). New Topics in Vitamin E Research (2006), NOVA Publishers
169. Zingg J.M., and Azzi A. Molecular Activities of Vitamin E. In: Meskin M.S., Bidlack W.R., and Randoph R.K. (Eds). Phytochemicals: Nutrient-Gene Interactions (2006), Taylor & Francis 175-206